Traditional Chinese Medicine Market Size, Share and Growth Forecast for 2025-2032

Traditional Chinese Medicine Market by Product (Traditional Chinese Medicine (TCM), Non-Traditional Chinese Medicine (Non-TCM))by Disease (Autism Spectrum Disorder (ASD),Attention Deficit Hyperactivity Disorder (ADHD)) and by Region

Industry: Healthcare

Published Date: February-2025

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 193

Report ID: PMRREP16219

Report Price

$4995*

Buy Now

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Product USPs / Features

    4.3. Recent Product Approval and Launches

    4.4. PESTLE Analysis

    4.5. Porter’s Analysis

    4.6. Regulatory Scenario

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Herbal Medicine Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing Adoption Of TCM

        5.2.2. Massive Infrastructure Planning for Global Manufacturing

        5.2.3. Favourable Regulatory and Reimbursement Scenario

        5.2.4. Increasing Research and Development

        5.2.5. Growth of Top Companies

        5.2.6. Mergers and Acquisitions

        5.2.7. Increasing Incidence of Lifestyle Diseases

    5.3. Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis – Impact Assessment

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By Disease

        6.1.3. By Region

    6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019 - 2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2019–2023

    7.2. Current and Future Market Value (US$ Mn) Projections, 2025–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis , 2019 – 2032

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019–2023

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2025–2032

        8.3.1. Traditional Chinese Medicine (TCM)

            8.3.1.1. Autism Spectrum Disorder (ASD)

            8.3.1.2. Attention Deficit Hyperactivity Disorder (ADHD)

        8.3.2. Non-Traditional Chinese Medicine (Non-TCM)

            8.3.2.1. Autism Spectrum Disorder (ASD)

            8.3.2.2. Attention Deficit Hyperactivity Disorder (ADHD)

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019 - 2032, by Disease

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Disease, 2019–2023

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2025–2032

        9.3.1. Autism Spectrum Disorder (ASD)

        9.3.2. Attention Deficit Hyperactivity Disorder (ADHD)

    9.4. Market Attractiveness Analysis By Disease

10. Global Market Analysis 2019 - 2032, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019–2023

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2025–2032

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. South Asia

        10.3.5. East Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa (Middle East and Africa (MEA))

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019 - 2032

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019–2023

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025–2032

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Product

        11.3.3. By Disease

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Product

        11.4.3. By Disease

    11.5. Country Level Analysis & Forecast

        11.5.1. U.S. Market Analysis

            11.5.1.1. Introduction

            11.5.1.2. Market Analysis and Forecast by Market Taxonomy

                11.5.1.2.1. By Product

                11.5.1.2.2. By Disease

        11.5.2. Canada Market Analysis

            11.5.2.1. Introduction

            11.5.2.2. Market Analysis and Forecast by Market Taxonomy

                11.5.2.2.1. By Product

                11.5.2.2.2. By Disease

    11.6. Market Trends

    11.7. Key Market Participants - Intensity Mapping

    11.8. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2019 - 2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019–2023

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025–2032

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Disease

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Product

        12.4.3. By Disease

    12.5. Country Level Analysis & Forecast

        12.5.1. Brazil Market Analysis

            12.5.1.1. Introduction

            12.5.1.2. Market Analysis and Forecast by Market Taxonomy

                12.5.1.2.1. By Product

                12.5.1.2.2. By Disease

        12.5.2. Mexico Market Analysis

            12.5.2.1. Introduction

            12.5.2.2. Market Analysis and Forecast by Market Taxonomy

                12.5.2.2.1. By Product

                12.5.2.2.2. By Disease

        12.5.3. Argentina Market Analysis

            12.5.3.1. Introduction

            12.5.3.2. Market Analysis and Forecast by Market Taxonomy

                12.5.3.2.1. By Product

                12.5.3.2.2. By Disease

    12.6. Market Trends

    12.7. Key Market Participants - Intensity Mapping

    12.8. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2019 - 2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019–2023

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Market Taxonomy, 2025–2032

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. France

            13.3.1.3. Italy

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. Russia

            13.3.1.7. BENELUX

            13.3.1.8. Nordic Countries

            13.3.1.9. Rest of Europe

        13.3.2. By Product

        13.3.3. By Disease

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By Disease

    13.5. Country Level Analysis & Forecast

        13.5.1. Germany Market Analysis

            13.5.1.1. Introduction

            13.5.1.2. Market Analysis and Forecast by Market Taxonomy

                13.5.1.2.1. By Product

                13.5.1.2.2. By Disease

        13.5.2. France Market Analysis

            13.5.2.1. Introduction

            13.5.2.2. Market Analysis and Forecast by Market Taxonomy

                13.5.2.2.1. By Product

                13.5.2.2.2. By Disease

        13.5.3. Italy Market Analysis

            13.5.3.1. Introduction

            13.5.3.2. Market Analysis and Forecast by Market Taxonomy

                13.5.3.2.1. By Product

                13.5.3.2.2. By Disease

        13.5.4. U.K. Market Analysis

            13.5.4.1. Introduction

            13.5.4.2. Market Analysis and Forecast by Market Taxonomy

                13.5.4.2.1. By Product

                13.5.4.2.2. By Disease

        13.5.5. Spain Market Analysis

            13.5.5.1. Introduction

            13.5.5.2. Market Analysis and Forecast by Market Taxonomy

                13.5.5.2.1. By Product

                13.5.5.2.2. By Disease

        13.5.6. Russia Market Analysis

            13.5.6.1. Introduction

            13.5.6.2. Market Analysis and Forecast by Market Taxonomy

                13.5.6.2.1. By Product

                13.5.6.2.2. By Disease

        13.5.7. Nordic Countries Market Analysis

            13.5.7.1. Introduction

            13.5.7.2. Market Analysis and Forecast by Market Taxonomy

                13.5.7.2.1. By Product

                13.5.7.2.2. By Disease

        13.5.8. BENELUX Market Analysis

            13.5.8.1. Introduction

            13.5.8.2. Market Analysis and Forecast by Market Taxonomy

                13.5.8.2.1. By Product

                13.5.8.2.2. By Disease

    13.6. Market Trends

    13.7. Key Market Participants - Intensity Mapping

    13.8. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2019 – 2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019–2023

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025–2032

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Product

        14.3.3. By Disease

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Disease

    14.5. Country Level Analysis & Forecast

        14.5.1. India Market Analysis

            14.5.1.1. Introduction

            14.5.1.2. Market Analysis and Forecast by Market Taxonomy

                14.5.1.2.1. By Product

                14.5.1.2.2. By Disease

        14.5.2. Thailand Market Analysis

            14.5.2.1. Introduction

            14.5.2.2. Market Analysis and Forecast by Market Taxonomy

                14.5.2.2.1. By Product

                14.5.2.2.2. By Disease

        14.5.3. Indonesia Market Analysis

            14.5.3.1. Introduction

            14.5.3.2. Market Analysis and Forecast by Market Taxonomy

                14.5.3.2.1. By Product

                14.5.3.2.2. By Disease

        14.5.4. Malaysia Market Analysis

            14.5.4.1. Introduction

            14.5.4.2. Market Analysis and Forecast by Market Taxonomy

                14.5.4.2.1. By Product

                14.5.4.2.2. By Disease

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2019 - 2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019–2023

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025–2032

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Product

        15.3.3. By Disease

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Disease

    15.5. Country Level Analysis & Forecast

        15.5.1. China Market Analysis

            15.5.1.1. Introduction

            15.5.1.2. Market Analysis and Forecast by Market Taxonomy

                15.5.1.2.1. By Product

                15.5.1.2.2. By Disease

        15.5.2. Japan Market Analysis

            15.5.2.1. Introduction

            15.5.2.2. Market Analysis and Forecast by Market Taxonomy

                15.5.2.2.1. By Product

                15.5.2.2.2. By Disease

        15.5.3. South Korea Market Analysis

            15.5.3.1. Introduction

            15.5.3.2. Market Analysis and Forecast by Market Taxonomy

                15.5.3.2.1. By Product

                15.5.3.2.2. By Disease

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2019 - 2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019–2023

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025–2032

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Product

        16.3.3. By Disease

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Disease

    16.5. Country Level Analysis & Forecast

        16.5.1. Australia Market Analysis

            16.5.1.1. Introduction

            16.5.1.2. Market Analysis and Forecast by Market Taxonomy

                16.5.1.2.1. By Product

                16.5.1.2.2. By Disease

        16.5.2. New Zealand Market Analysis

            16.5.2.1. Introduction

            16.5.2.2. Market Analysis and Forecast by Market Taxonomy

                16.5.2.2.1. By Product

                16.5.2.2.2. By Disease

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2019 - 2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019–2023

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025–2032

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. Türkiye

            17.3.1.3. Northern Africa

            17.3.1.4. South Africa

            17.3.1.5. Rest of Middle East and Africa

        17.3.2. By Product

        17.3.3. By Disease

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Disease

    17.5. Country Level Analysis & Forecast

        17.5.1. GCC Countries Market Analysis

            17.5.1.1. Introduction

            17.5.1.2. Market Analysis and Forecast by Market Taxonomy

                17.5.1.2.1. By Product

                17.5.1.2.2. By Disease

        17.5.2. Türkiye Market Analysis

            17.5.2.1. Introduction

            17.5.2.2. Market Analysis and Forecast by Market Taxonomy

                17.5.2.2.1. By Product

                17.5.2.2.2. By Disease

        17.5.3. Northern Africa Market Analysis

            17.5.3.1. Introduction

            17.5.3.2. Market Analysis and Forecast by Market Taxonomy

                17.5.3.2.1. By Product

                17.5.3.2.2. By Disease

        17.5.4. South Africa Market Analysis

            17.5.4.1. Introduction

            17.5.4.2. Market Analysis and Forecast by Market Taxonomy

                17.5.4.2.1. By Product

                17.5.4.2.2. By Disease

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Share Analysis of Top Players

    18.3. Market Presence Analysis

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Branding and Promotional Strategies

    19.3. Key Development Analysis

    19.4. Competition Deep Dive

        19.4.1. Tongrentang

            19.4.1.1. Overview

            19.4.1.2. Product Portfolio

            19.4.1.3. Key Financials

            19.4.1.4. Sales Footprint

            19.4.1.5. SWOT Analysis

            19.4.1.6. Strategy Overview

                19.4.1.6.1. Marketing Strategy

                19.4.1.6.2. Product Strategy

                19.4.1.6.3. Channel Strategy

        19.4.2. Zhongxin Pharmaceuticals

            19.4.2.1. Overview

            19.4.2.2. Product Portfolio

            19.4.2.3. Key Financials

            19.4.2.4. Sales Footprint

            19.4.2.5. SWOT Analysis

            19.4.2.6. Strategy Overview

                19.4.2.6.1. Marketing Strategy

                19.4.2.6.2. Product Strategy

                19.4.2.6.3. Channel Strategy

        19.4.3. Tianjin Tasly Group

            19.4.3.1. Overview

            19.4.3.2. Product Portfolio

            19.4.3.3. Key Financials

            19.4.3.4. Sales Footprint

            19.4.3.5. SWOT Analysis

            19.4.3.6. Strategy Overview

                19.4.3.6.1. Marketing Strategy

                19.4.3.6.2. Product Strategy

                19.4.3.6.3. Channel Strategy

        19.4.4. Yuannan Baiyao

            19.4.4.1. Overview

            19.4.4.2. Product Portfolio

            19.4.4.3. Key Financials

            19.4.4.4. Sales Footprint

            19.4.4.5. SWOT Analysis

            19.4.4.6. Strategy Overview

                19.4.4.6.1. Marketing Strategy

                19.4.4.6.2. Product Strategy

                19.4.4.6.3. Channel Strategy

        19.4.5. Solstice Medicine Company, Inc.

            19.4.5.1. Overview

            19.4.5.2. Product Portfolio

            19.4.5.3. Key Financials

            19.4.5.4. Sales Footprint

            19.4.5.5. SWOT Analysis

            19.4.5.6. Strategy Overview

                19.4.5.6.1. Marketing Strategy

                19.4.5.6.2. Product Strategy

                19.4.5.6.3. Channel Strategy

        19.4.6. Shanghai Sundise Traditional Chinese Medicine Co., Ltd

            19.4.6.1. Overview

            19.4.6.2. Product Portfolio

            19.4.6.3. Key Financials

            19.4.6.4. Sales Footprint

            19.4.6.5. SWOT Analysis

            19.4.6.6. Strategy Overview

                19.4.6.6.1. Marketing Strategy

                19.4.6.6.2. Product Strategy

                19.4.6.6.3. Channel Strategy

        19.4.7. China Chinese Medicine Holding Co., Ltd.

            19.4.7.1. Overview

            19.4.7.2. Product Portfolio

            19.4.7.3. Key Financials

            19.4.7.4. Sales Footprint

            19.4.7.5. SWOT Analysis

            19.4.7.6. Strategy Overview

                19.4.7.6.1. Marketing Strategy

                19.4.7.6.2. Product Strategy

                19.4.7.6.3. Channel Strategy

        19.4.8. Hunan goldliloo pharmaceutical Co., Ltd

            19.4.8.1. Overview

            19.4.8.2. Product Portfolio

            19.4.8.3. Key Financials

            19.4.8.4. Sales Footprint

            19.4.8.5. SWOT Analysis

            19.4.8.6. Strategy Overview

                19.4.8.6.1. Marketing Strategy

                19.4.8.6.2. Product Strategy

                19.4.8.6.3. Channel Strategy

        19.4.9. Wanbang Pharma Group Corp.

            19.4.9.1. Overview

            19.4.9.2. Product Portfolio

            19.4.9.3. Key Financials

            19.4.9.4. Sales Footprint

            19.4.9.5. SWOT Analysis

            19.4.9.6. Strategy Overview

                19.4.9.6.1. Marketing Strategy

                19.4.9.6.2. Product Strategy

                19.4.9.6.3. Channel Strategy

        19.4.10. Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.

            19.4.10.1. Overview

            19.4.10.2. Product Portfolio

            19.4.10.3. Key Financials

            19.4.10.4. Sales Footprint

            19.4.10.5. SWOT Analysis

            19.4.10.6. Strategy Overview

                19.4.10.6.1. Marketing Strategy

                19.4.10.6.2. Product Strategy

                19.4.10.6.3. Channel Strategy

        19.4.11. Pfizer Inc.

            19.4.11.1. Overview

            19.4.11.2. Product Portfolio

            19.4.11.3. Key Financials

            19.4.11.4. Sales Footprint

            19.4.11.5. SWOT Analysis

            19.4.11.6. Strategy Overview

                19.4.11.6.1. Marketing Strategy

                19.4.11.6.2. Product Strategy

                19.4.11.6.3. Channel Strategy

        19.4.12. Eli Lilly and Company

            19.4.12.1. Overview

            19.4.12.2. Product Portfolio

            19.4.12.3. Key Financials

            19.4.12.4. Sales Footprint

            19.4.12.5. SWOT Analysis

            19.4.12.6. Strategy Overview

                19.4.12.6.1. Marketing Strategy

                19.4.12.6.2. Product Strategy

                19.4.12.6.3. Channel Strategy

        19.4.13. Novartis AG

            19.4.13.1. Overview

            19.4.13.2. Product Portfolio

            19.4.13.3. Key Financials

            19.4.13.4. Sales Footprint

            19.4.13.5. SWOT Analysis

            19.4.13.6. Strategy Overview

                19.4.13.6.1. Marketing Strategy

                19.4.13.6.2. Product Strategy

                19.4.13.6.3. Channel Strategy

        19.4.14. GlaxoSmithKline PLC

            19.4.14.1. Overview

            19.4.14.2. Product Portfolio

            19.4.14.3. Key Financials

            19.4.14.4. Sales Footprint

            19.4.14.5. SWOT Analysis

            19.4.14.6. Strategy Overview

                19.4.14.6.1. Marketing Strategy

                19.4.14.6.2. Product Strategy

                19.4.14.6.3. Channel Strategy

        19.4.15. Mallinckrodt Pharmaceuticals

            19.4.15.1. Overview

            19.4.15.2. Product Portfolio

            19.4.15.3. Key Financials

            19.4.15.4. Sales Footprint

            19.4.15.5. SWOT Analysis

            19.4.15.6. Strategy Overview

                19.4.15.6.1. Marketing Strategy

                19.4.15.6.2. Product Strategy

                19.4.15.6.3. Channel Strategy

        19.4.16. Hisamitsu Pharmaceutical Co., Inc.

            19.4.16.1. Overview

            19.4.16.2. Product Portfolio

            19.4.16.3. Key Financials

            19.4.16.4. Sales Footprint

            19.4.16.5. SWOT Analysis

            19.4.16.6. Strategy Overview

                19.4.16.6.1. Marketing Strategy

                19.4.16.6.2. Product Strategy

                19.4.16.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate